Clinical Trial Update: fFN & E3 in the Prediction of PTB in Women With Twin Pregnancies Receiving 17OHP or Placebo

View source ↗

Summary

A clinical trial evaluating fetal fibronectin and E3 for predicting preterm birth in twin pregnancies receiving 17-hydroxyprogesterone caproate or placebo has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth
• Preterm Delivery

Drugs mentioned

• 17 α-hydroxyprogesterone caproate (17α-hydroxyprogesterone caproate)

Snippet

Sponsor: Obstetrix Medical Group | Conditions: Preterm Delivery, Preterm Birth | Status: WITHDRAWN